Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
15.63
+0.18 (1.17%)
Aug 1, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
FILSPARI
132.22M
Log In
Log In
Log In
Log In
Upgrade
FILSPARI Growth
352.69%
Log In
Log In
Log In
Log In
Upgrade
Tiopronin Products
94.49M
Log In
Log In
Log In
Log In
Upgrade
Tiopronin Products Growth
-3.91%
Log In
Log In
Log In
Log In
Upgrade
Bile Acid Products
-
Log In
Log In
Log In
Log In
Upgrade
Bile Acid Products Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
226.71M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
77.76%
Log In
Log In
Log In
Log In
Upgrade